News

What’s Causing Cancers at Air Force Bases?


 

On its website, though, the Air Force Medical Service now says that the findings from 2 decades ago may have changed.

The findings from the new study are not final. The USAF is continuing its investigation, including conducting an epidemiological study of cancers within the missile community. In the meantime, Air Force Global Strike Command Public Affairs says that, in response to the review panel’s recommendations, Gen. Bussiere has directed that facilities be deep cleaned regularly, signage denoting the presence of polychlorinated biphenyls be updated, and burning no longer allowed as a means of destroying classified materials inside the facilities.

Notably, the changes will also include improving communication and coordination between medical personnel and missile community members. Bussiere directed his staff to explore specifically assigning medical professionals to ICBM units, to have a better understanding of the environment and missions. He also ordered further engagement with personnel who work with known occupational hazards to collect more data and information. While awaiting the eventual replacement of the Minuteman III ICBM with the LGM-35A Sentinel, preventive maintenance and environmental upgrades will be prioritized and any upgrade or new piece of equipment will be “scrutinized for hazards.”

The USAF has also established a website to address the missileer community’s concerns.

Pages

Recommended Reading

CLL treatment: More infections among real-world patients
Federal Practitioner
CLL and surgery are more compatible than ever
Federal Practitioner
B-cell cancers: Sparse insight into preventing infections
Federal Practitioner
MRD: Powerful metric for CLL research
Federal Practitioner
Price of CLL Rx rises, despite competition
Federal Practitioner
Relapsed CLL: New approaches prolong survival
Federal Practitioner
Frontline CLL treatment: Avoiding adverse events
Federal Practitioner
“Terrific progress”: Adding blinatumomab for infant leukemia
Federal Practitioner
Number of cancer survivors with functional limitations doubled in 20 years
Federal Practitioner
CLL: Venetoclax combos top first-line chemoimmunotherapy
Federal Practitioner